A test of the ability of leukocytes to reduce nitroblue tetrazolium from a colorless state to a deep blue. It is used as a marker of nitric oxide synthase. The reduction of NBT may be used in the rapid diagnosis of urinary tract infections and in the study and diagnosis of chronic granulomatous disease and other illnesses in which there are defects in the oxidative metabolism of phagocytic white blood cells.